Both in Pharmaceuticals
ANI Pharmaceuticals vs Phibro Animal Health
Over the past year ANIP returned −23.8% and PAHC returned −12.4%; their daily moves had a correlation of 0.24.
ANIP −23.8% PAHC −12.4%Growth of $1, one year, split-adjusted
| Metric | ANIP | PAHC |
|---|---|---|
| Price | $71.71 | $38.00 |
| Market cap | $1.65B | $1.54B |
| Today | +1.47% | −1.91% |
| 1 month | −1.2% | +2.2% |
| 6 months | −15.3% | −32.4% |
| Year to date | −9.2% | +1.7% |
| 1 year | −20.8% | −9.7% |
| Revenue growth (YoY) | +25.9% | +4.8% |
| Gross margin | 62.4% | 33.9% |
| Net margin | 8.6% | 5.5% |
| P/E (TTM) | 16.5× | 15.5× |
| Price / sales | 1.7× | 1.0× |
| Net cash | -$234.7M | -$650.8M |
| Dividend yield | — | 1.26% |
| Volatility (60d) | 26.6% | 29.8% |
| Short % of float | 18.1% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).